2025年國家留學基金管理委員會（CSC）獎學金錄取結果近日公布。仁醫(yī)醫(yī)療今年共協助35位醫(yī)生提交申請，其中31人成功獲得國家公派出國留學資格，平均每人將獲得約36萬元人民幣獎學金。盡管仍有4位醫(yī)生因各種原因未能通過評審，但他們的努力同樣值得尊重，我們也將繼續(xù)陪伴他們，明年再戰(zhàn)?；仡欉^去幾年的數據：2022年申請10人，全部獲批；2023年申請18人，通過16人；2024年申請26人，通過22人；而2025年，申請人數首次突破30人，創(chuàng)下了31人通過的新高。這些獲得CSC資助的醫(yī)生將赴德國多所知名高校，跟隨德國國家科學院院士、歐洲重要醫(yī)學學會主席以及各專業(yè)領域的學科帶頭人攻讀臨床醫(yī)學MD博士，錄取院校包括海德堡大學、柏林夏洛特醫(yī)科大學、亞琛工業(yè)大學、慕尼黑大學、哥廷根大學、慕尼黑工業(yè)大學、吉森大學和基爾大學等。國家對醫(yī)學與科技人才的持續(xù)投入，讓我們看到中國醫(yī)生在全球醫(yī)學舞臺上不斷拓展的可能性。仁醫(yī)醫(yī)療將一如既往地為優(yōu)秀青年醫(yī)生的職業(yè)發(fā)展提供支持與保障，助力更多醫(yī)生邁出關鍵一步，見證他們走出去、成長起來，再帶著新的視野和能力回到臨床。中國真正優(yōu)秀的醫(yī)生應該成為中國社會一群有道德、有信仰、有理想、有能力的人。

The results of the 2025 China Scholarship Council (CSC) government-sponsored study abroad program have recently been announced. This year, Gloryren assisted a total of 35 doctors in CSC applications, with 31 successfully securing the national scholarship for overseas study. On average, each recipient will receive a scholarship of approximately 360,000 Chinese yuan. While four applicants failed to get the scholarship this time due to various reasons, their efforts are equally commendable, and we will continue supporting them for next year’s application. Looking back at Gloryren’s data from the past few years: in 2022, 10 applicants were all approved; in 2023, 16 out of 18 applications were approved; in 2024, 22 out of 26 applications were approved. In 2025, the number of applicants exceeded 30 for the first time, reaching a new high of 31 approvals. These doctors funded by CSC will pursue MD degrees at renowned universities in Germany, studying under members of the German National Academy of Sciences Leopoldina, presidents of major European scientific organizations, and key academic leaders in various specialties. Admitting universities include Heidelberg University, Charité - Universit?tsmedizin Berlin, RWTH Aachen University, Ludwig Maximilian University of Munich, University of G?ttingen, Technical University of Munich, University of Giessen, and Kiel University. The Chinese government’s sustained investment in medical and technological talents has demonstrated the expanding possibilities for Chinese doctors on the global medical stage. Gloryren will as always provide support and guarantees for the career development of outstanding young doctors, helping more doctors take this crucial step forward, witness their growth through studying abroad, and return to clinical practice with new perspectives and capabilities. China's truly outstanding doctors should embody ethics, faith, ideals, and professional competence—becoming a driving force for progress in society.